Innate Pharma announces conference call and webcast for Full Year 2022 financial results

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, March 23, 2023 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2022. 
 
Speakers during the call will be: 

• Mondher Mahjoubi, Chief Executive Officer 
• Joyson Karakunnel, Executive Vice President, Chief Medical Officer
• Yannis Morel, Executive Vice President, Product Portfolio Strategy & Business Development 
• Frédéric Lombard, Senior Vice President, Chief Financial Officer

Details for the Virtual Event

The live webcast will be available at the following link: 
https://events.q4inc.com/attendee/611394672 

Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4E60253 

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.